100 studies (1 from unattributed sources) on Mots-c curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
| Manufacturer | Batches | Avg purity | |
|---|---|---|---|
| Verified Peptides | 20 | 99.56% | View COA → |
| Uther Peptide | 11 | 99.4% | View COA → |
| Qingdao Sigma Chemical | 8 | 99.42% | View COA → |
| (unknown) | 7 | 99.53% | View COA → |
| Shanghai Sigma Audley Ssa | 7 | 99.52% | View COA → |
| Lilipeptide | 7 | 99.23% | View COA → |
| Reta Peptide | 6 | 99.57% | View COA → |
| Aminos Research | 5 | 99.76% | View COA → |
Recent certificates: #21905 (98.7%) · #14811 (99.174%) · #21906 (99.4%) · #14490 (99.7%) · #14578 (99.298%) · #13237 (99.139%)
Manufacturers with published third-party certificates of analysis for Mots-c. Open a vendor to see every batch we've verified.
No digested studies found for Mots-c yet.
Free, no account — handy when you're working with Mots-c.